AVDE - Avantis International Equity ETF
| Assets | $930.07M |
| NAV | $63.27 |
| Expense Ratio | 0.23% |
| PE Ratio | 19.70 |
| Beta (5Y) | 1.03 |
| Dividend (ttm) | $1.24 |
| Dividend Yield | 1.96% |
| Ex-Dividend Date | Jun 22, 2021 |
| 1-Year Return | - |
| Trading Day | July 29 |
| Last Price | $63.98 |
| Previous Close | $63.49 |
| Change ($) | 0.49 |
| Change (%) | 0.77% |
| Day's Open | 63.93 |
| Day's Range | 63.93 - 64.14 |
| Day's Volume | 18,741 |
| 52-Week Range | 46.41 - 65.08 |
Fund Description
The investment seeks long-term capital appreciation. The fund invests primarily in a diverse group of non-U.S. companies across countries, market sectors and industry groups. It may invest in companies of all market capitalizations. Under normal market conditions, the fund will invest at least 80% of its assets in equity securities. It also may invest in derivative instruments such as futures contracts, currency forwards, and swap agreements.
| Asset Class Equity | Inception Date Sep 24, 2019 |
| Exchange NYSEARCA | Ticker Symbol AVDE |
| Index Tracked MSCI WORLD EX USA IMI INDEX | |
Top 10 Holdings
6.31% of assets| Name | Symbol | Weight |
|---|---|---|
| Roche Holding AG | ROG.SW | 1.11% |
| ASML Holding | ASML | 0.80% |
| LVMH Moet Hennessy Louis Vuitton SE | MC.PA | 0.74% |
| Nestle SA | NESN.SW | 0.63% |
| Novo Nordisk A/S | NVO | 0.59% |
| AstraZeneca | AZN | 0.55% |
| Novartis AG ADR | NVSN.MX | 0.52% |
| Royal Bank of Canada | RY.TO | 0.49% |
| BHP Group | BHP | 0.45% |
| Rio Tinto | RIO | 0.43% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 22, 2021 | $0.699 | Jun 25, 2021 |
| Dec 17, 2020 | $0.542 | Dec 23, 2020 |
| Jun 23, 2020 | $0.391 | Jun 29, 2020 |
| Dec 27, 2019 | $0.157 | Dec 30, 2019 |
International equities gained Thursday, with emerging markets and related exchange traded funds taking charge as updated Chinese economic growth data fueled expectations of more liquidity. Chinese stock...
International markets, notably European stocks, led the charge on Wednesday after the previous session's sharp selling, with higher commodity prices and the earnings season supporting gains. Investors c...